Spectrum Pharmaceuticals, Inc.[SPPI] stock saw a move by 3.58% on , touching 1.39 million. Based on the recent volume, Spectrum Pharmaceuticals, Inc. stock traders appear to be active. The most recent trading volume of SPPI shares recorded 109.07M shares, which represents the daily volume of traded shares. Analysts estimates state that Spectrum Pharmaceuticals, Inc. [SPPI] stock could reach median target price of $19.00.

Spectrum Pharmaceuticals, Inc. [SPPI] stock additionally went up by +9.58% in the period of the 7 days, recording a gain in performance by 23.62% in the last 30 days. The yearly more of SPPI stock is set at -23.00% by far, with shares price recording returns by 29.64% in the latest quarter. Over the past six months, SPPI shares showcased 24.87% increase. SPPI saw -25.74% change opposing the low price in the last 12 months, also recording 58.20% compared to high within the same period of time.

Spectrum Pharmaceuticals, Inc. [NASDAQ:SPPI]: Analyst Rating and Earnings

Its stock price has been found in the range of 6.22 to 13.25. This is compared to its latest closing price of $9.50.

Pay attention to the next-scheduled financial results for this company to be released, which is slated for Thu 27 Feb (In 81 Days).

Fundamental Analysis of Spectrum Pharmaceuticals, Inc. [SPPI]

Now let’s turn to look at profitability: with a current Operating Margin for Spectrum Pharmaceuticals, Inc. [SPPI] sitting at -119.98 and its Gross Margin at +49.83.

This company’s Return on Total Capital is -38.99, and its Return on Invested Capital has reached -46.30%. Its Return on Equity is -37.82, and its Return on Assets is -27.06. These metrics suggest that this Spectrum Pharmaceuticals, Inc. does a poor job of managing its

assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

What about valuation? This company’s Enterprise Value to EBITDA is -7.98. The Enterprise Value to Sales for this firm is now 27.89. Spectrum Pharmaceuticals, Inc. [SPPI] has a Price to Book Ratio of 3.41.

Shifting the focus to workforce efficiency, Spectrum Pharmaceuticals, Inc. [SPPI] earns $465,247 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 3.22 and its Total Asset Turnover is 0.25. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 2.86 and its Current Ratio is 2.90. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Spectrum Pharmaceuticals, Inc. [SPPI] has 109.07M shares outstanding, amounting to a total market cap of $1.07B. Its stock price has been found in the range of 6.22 to 13.25. At its current price, it has moved down by -25.74% from its 52-week high, and it has moved up 58.20% from its 52-week low.

This stock’s Beta value is currently 2.60, which indicates that it is 5.74% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 70.96. This RSI suggests that Spectrum Pharmaceuticals, Inc. is currently Overbought.

Conclusion: Is Spectrum Pharmaceuticals, Inc. [SPPI] a Reliable Buy?

Shares of Spectrum Pharmaceuticals, Inc. [SPPI], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.